We propose progression of photoreceptor loss in the retina immediately surrounding the area of EZ-loss represents a measure of the leading front of the disease and, as such, may prove a valuable outcome measure for clinical trials of ABCA4-related retinopathy. The gene discussed is ABCA4; the disease is retinal disorder.